Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Virtual Congress 2020

Maximising the benefit of immuno-oncology

Who should get an I-O combination?

Date

17 Oct 2020

Session

Maximising the benefit of immuno-oncology

Topics

Immunotherapy

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Marina Garassino

Authors

M.C. Garassino

Author affiliations

  • Thoracic Unit, Istituto Nazionale dei Tumori di Milano - Fondazione IRCCS, 20133 - Milan/IT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Biomarkers

Presenter: Naiyer Rizvi

Session: Maximising the benefit of immuno-oncology

Resources:

Slides

Webcast

What to do post-IO failure

Presenter: Pilar Garrido Lopez

Session: Maximising the benefit of immuno-oncology

Resources:

Slides

Webcast

Q&A and live discussion

Presenter: Natasha Leighl

Session: Maximising the benefit of immuno-oncology

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.